Inventor
DUNCTON MATTHEW
US48 patents
⚠️ This page may combine multiple inventors who share the name “DUNCTON MATTHEW”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
RIGEL PHARMACEUTICALS INC
29 patentsUS9566278B2Feb 14, 2017
Protein kinase C inhibitors and uses thereof
RIGEL PHARMACEUTICALS INC6 citations84
US9475781B2Oct 25, 2016
Fumarate analogs and uses thereof
RIGEL PHARMACEUTICALS INC11 citations84
US9321763B2Apr 26, 2016
Protein kinase C inhibitors and uses thereof
RIGEL PHARMACEUTICALS INC6 citations84
US8377924B2Feb 19, 2013
Protein kinase C inhibitors and uses thereof
RIGEL PHARMACEUTICALS INC9 citations82
US10941135B2Mar 9, 2021
Nrf2 activating compounds and uses thereof
RIGEL PHARMACEUTICALS INC1 citations73
US9913843B2Mar 13, 2018
Protein kinase C inhibitors and uses thereof
RIGEL PHARMACEUTICALS INC3 citations73
US9845307B2Dec 19, 2017
Nrf2 activating compounds and uses thereof
RIGEL PHARMACEUTICALS INC2 citations73
US9801866B2Oct 31, 2017
Fumarate analogs and uses thereof
RIGEL PHARMACEUTICALS INC3 citations73
US9732070B2Aug 15, 2017
Protein kinase C inhibitors and uses thereof
RIGEL PHARMACEUTICALS INC4 citations73
US9701647B2Jul 11, 2017
Tetrazolones as a carboxylic acid bioisosteres
RIGEL PHARMACEUTICALS INC2 citations73
US9682976B2Jun 20, 2017
Protein kinase C inhibitors and uses thereof
RIGEL PHARMACEUTICALS INC3 citations73
US9181222B2Nov 10, 2015
Protein kinase C inhibitors and uses thereof
RIGEL PHARMACEUTICALS INC4 citations73
US9169249B2Oct 27, 2015
Protein kinase C inhibitors and uses thereof
RIGEL PHARMACEUTICALS INC4 citations73
US8754251B2Jun 17, 2014
Cyclopropyl PIDA boronate
RIGEL PHARMACEUTICALS INC4 citations73
US9149475B2Oct 6, 2015
Protein kinase C inhibitors and uses thereof
RIGEL PHARMACEUTICALS INC5 citations71
US11279686B2Mar 22, 2022
Nrf2 activating compounds and uses thereof
RIGEL PHARMACEUTICALS INC0 citations63
US9845311B2Dec 19, 2017
Nrf2 activating compounds and uses thereof
RIGEL PHARMACEUTICALS INC1 citations63
US9439888B2Sep 13, 2016
Tetrazolones as a carboxylic acid bioisosteres
RIGEL PHARMACEUTICALS INC2 citations63
US11129819B2Sep 28, 2021
Fumarate analogs and uses thereof
RIGEL PHARMACEUTICALS INC0 citations62
US10844040B2Nov 24, 2020
Nrf2 activating compounds and uses thereof
RIGEL PHARMACEUTICALS INC0 citations52
US10792282B2Oct 6, 2020
Protein kinase C inhibitors and uses thereof
RIGEL PHARMACEUTICALS INC0 citations52
US10647697B2May 12, 2020
Nrf2 activating compounds and uses thereof
RIGEL PHARMACEUTICALS INC0 citations52
US10556881B2Feb 11, 2020
Nrf2 activating compounds and uses thereof
RIGEL PHARMACEUTICALS INC0 citations52
US10493066B2Dec 3, 2019
Fumarate analogs and uses thereof
RIGEL PHARMACEUTICALS INC0 citations52
US10450280B2Oct 22, 2019
Tetrazolones as a carboxylic acid bioisosteres
RIGEL PHARMACEUTICALS INC0 citations52
US10005777B2Jun 26, 2018
Protein kinase C inhibitors and uses thereof
RIGEL PHARMACEUTICALS INC0 citations52
US9108990B2Aug 18, 2015
Cyclopropyl MIDA boronate
RIGEL PHARMACEUTICALS INC0 citations52
US9062068B2Jun 23, 2015
Protein kinase C inhibitors and uses thereof
RIGEL PHARMACEUTICALS INC0 citations52
US11174246B2Nov 16, 2021
Direct AMPK activators
RIGEL PHARMACEUTICALS INC0 citations49
NFLECTION THERAPEUTICS INC
8 patentsUS11161845B2Nov 2, 2021
Pyrrolopyridine-aniline compounds for treatment of dermal disorders
NFLECTION THERAPEUTICS INC9 citations85
US12065439B2Aug 20, 2024
Pyrrolopyridine-aniline compounds for treatment of dermal disorders
NFLECTION THERAPEUTICS INC2 citations72
US10988483B2Apr 27, 2021
Fused heteroaromatic-aniline compounds for treatment of dermal disorders
NFLECTION THERAPEUTICS INC5 citations72
US12466818B2Nov 11, 2025
Thienyl-aniline compounds for treatment of dermal disorders
NFLECTION THERAPEUTICS INC0 citations62
US12428418B2Sep 30, 2025
Pyrrolopyridine-aniline compounds for treatment of dermal disorders
NFLECTION THERAPEUTICS INC0 citations62
US11572344B2Feb 7, 2023
Cyanoaryl-aniline compounds for treatment of dermal disorders
NFLECTION THERAPEUTICS INC1 citations62
US11542271B2Jan 3, 2023
Fused heteroaromatic-aniline compounds for treatment of dermal disorders
NFLECTION THERAPEUTICS INC0 citations62
US12378240B2Aug 5, 2025
Naphthyridinone-aniline compounds for treatment of dermal disorders
NFLECTION THERAPEUTICS INC0 citations51
TERRAN BIOSCIENCES INC
4 patentsUS12435036B2Oct 7, 2025
Salts and solid forms of (R)-1-(5-methoxy-1H-indol-1-yl)-n,n-dimethylpropan-2-amine
TERRAN BIOSCIENCES INC0 citations60
US12319652B2Jun 3, 2025
Salts and solid forms of (R)-1-(5-methoxy-1H-indol-1-yl)-N,N-dimethylpropan-2-amine
TERRAN BIOSCIENCES INC0 citations60
US12269818B2Apr 8, 2025
Analogs of xanomeline
TERRAN BIOSCIENCES INC0 citations60
US12234216B2Feb 25, 2025
Isotopologues salts, crystalline forms, stereoisomers, of methylone and ethylone and methods of use thereof
TERRAN BIOSCIENCES INC0 citations60